Physician profile
Christopher Samujh
NPI 1588878904
$4,085.65
in general payments reported to CMS, 2019-2025
7 companies · $1,728 in 2025
The $1,728 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.48 · 2020: $212 · 2021: $335 · 2022: $1,530 · 2023: $267 · 2025: $1,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,111 · Food and Beverage: $806 · Education: $77.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,111.19 |
| Food and Beverage | $806.47 |
| Education | $77.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,511.91 | 2019-2025 | Oxford, Tapestry, Persona |
| Kerecis Limited | $316.76 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Depuy Synthes Sales INC. | $117.36 | 2022 | |
| Stryker Corporation | $79.84 | 2021 | |
| Baxter Healthcare | $24.67 | 2025 | Tisseel |
| Si-Bone, INC. | $17.99 | 2025 | |
| Kci USA, INC. | $17.12 | 2023 | V.A.C.Ulta, Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Samujh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.